GlobeNewswire 18/03/2024 Adverum Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Pip...
GlobeNewswire 28/02/2024 Adverum Biotechnologies to Participate in the TD Cowen 44th Annual Health Care Conference
GlobeNewswire 12/02/2024 Adverum Biotechnologies to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Confe...
GlobeNewswire 08/02/2024 Adverum Biotechnologies Announces Positive Preliminary Efficacy and Safety Data from LUNA Phase 2 Tr...
GlobeNewswire 05/02/2024 Adverum Biotechnologies Announces $127.5 Million Private Placement Financing
GlobeNewswire 01/02/2024 Adverum Biotechnologies will Host Webcast to Review LUNA Phase 2 Preliminary Efficacy and Safety Res...
GlobeNewswire 01/02/2024 Opthea Strengthens Team with Key Clinical and Regulatory Hires
GlobeNewswire 29/01/2024 Adverum Biotechnologies Appoints Romuald Corbau, Ph.D. as Chief Scientific Officer
GlobeNewswire 07/12/2023 Adverum Biotechnologies to Present LUNA Preliminary Efficacy and Safety Data at the 47th Annual Meet...
GlobeNewswire 28/11/2023 Adverum Biotechnologies to Participate in the Evercore ISI 6th Annual HealthCONx Conference
GlobeNewswire 09/11/2023 Adverum Biotechnologies Reports Third Quarter 2023 Financial Results and Pipeline Highlights
GlobeNewswire 06/11/2023 Adverum Biotechnologies Appoints C. David Nicholson, Ph.D. to its Board of Directors
GlobeNewswire 04/11/2023 Adverum Biotechnologies Announces 3-Year Efficacy and Safety Results from the OPTIC Extension Study ...
GlobeNewswire 26/09/2023 Adverum Biotechnologies Announces Positive Aflibercept Protein Level Data from the LUNA Phase 2 Tria...
GlobeNewswire 21/09/2023 Adverum Biotechnologies to Participate in Upcoming Investor Conferences
GlobeNewswire 05/09/2023 Adverum Biotechnologies to Participate in the H.C. Wainwright 25th Annual Global Investment Conferen...
GlobeNewswire 21/08/2023 Adverum Biotechnologies Appoints Andrew Ramelmeier, Ph.D. as Chief Technology Officer
GlobeNewswire 29/03/2022 Nkarta Appoints Manufacturing Technology Executive, Angela Thedinga, to Board of Directors
GlobeNewswire 17/03/2022 Adverum Appoints Rabia Gurses Ozden, M.D. and Soo J. Hong, M.B.A., to Board of Directors
GlobeNewswire 28/02/2022 Adverum Biotechnologies to Participate in the 42nd Annual Cowen Healthcare Conference
GlobeNewswire 07/02/2022 Adverum Biotechnologies Appoints Richard Beckman M.D. as Chief Medical Officer
GlobeNewswire 06/01/2022 Adverum Biotechnologies Appoints Star Seyedkazemi, Pharm.D. as Chief Development Officer
GlobeNewswire 04/01/2022 Adverum Biotechnologies Granted Orphan Drug Designation by FDA for Gene Therapy Candidate in Preclin...
GlobeNewswire 21/12/2021 Adverum Biotechnologies Provides ADVM-022 Development Update and Anticipated Corporate Milestones fo...
GlobeNewswire 09/12/2021 SparingVision Strengthens Leadership Team with the Appointment of Dr Mehdi Gasmi as Chief Operating ...